Nidal Muvarak

980 total citations
17 papers, 772 citations indexed

About

Nidal Muvarak is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Nidal Muvarak has authored 17 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Nidal Muvarak's work include Immune Cell Function and Interaction (3 papers), Cancer therapeutics and mechanisms (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Nidal Muvarak is often cited by papers focused on Immune Cell Function and Interaction (3 papers), Cancer therapeutics and mechanisms (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Nidal Muvarak collaborates with scholars based in United States. Nidal Muvarak's co-authors include Philip W. Zoltick, Antoneta Radu, William H. Peranteau, Andrea Badillo, Ping Zhang, Kenneth W. Liechty, Jens C. Eickhoff, Naomi C. Chesler, Feyruz V. Rassool and Alan W. Flake and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Cell.

In The Last Decade

Nidal Muvarak

17 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nidal Muvarak United States 10 338 157 143 114 108 17 772
Angus M. Tester Australia 10 410 1.2× 463 2.9× 49 0.3× 49 0.4× 89 0.8× 17 1.1k
Carola Leipner Germany 12 251 0.7× 86 0.5× 39 0.3× 50 0.4× 91 0.8× 15 790
Seong‐Jin Kim United States 9 373 1.1× 123 0.8× 102 0.7× 39 0.3× 140 1.3× 11 758
Dean Kavanagh United Kingdom 15 245 0.7× 116 0.7× 30 0.2× 40 0.4× 45 0.4× 30 876
Françoise Créchet France 11 213 0.6× 152 1.0× 69 0.5× 62 0.5× 117 1.1× 20 703
Sarah E. Dunsmore United States 14 222 0.7× 134 0.9× 36 0.3× 45 0.4× 415 3.8× 22 924
Teresa I. Mitchell United States 11 487 1.4× 304 1.9× 26 0.2× 75 0.7× 70 0.6× 14 1.0k
Robert O. Mitchell United States 7 565 1.7× 148 0.9× 244 1.7× 77 0.7× 59 0.5× 10 1.1k
Aline B. Scandurro United States 15 470 1.4× 241 1.5× 43 0.3× 66 0.6× 121 1.1× 20 1.3k
Qinglang Li United States 6 356 1.1× 250 1.6× 40 0.3× 56 0.5× 347 3.2× 6 1.1k

Countries citing papers authored by Nidal Muvarak

Since Specialization
Citations

This map shows the geographic impact of Nidal Muvarak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nidal Muvarak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nidal Muvarak more than expected).

Fields of papers citing papers by Nidal Muvarak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nidal Muvarak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nidal Muvarak. The network helps show where Nidal Muvarak may publish in the future.

Co-authorship network of co-authors of Nidal Muvarak

This figure shows the co-authorship network connecting the top 25 collaborators of Nidal Muvarak. A scholar is included among the top collaborators of Nidal Muvarak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nidal Muvarak. Nidal Muvarak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Muvarak, Nidal, Haishan Li, Tyler Lahusen, et al.. (2022). Safety and durability of AGT103-T autologous T cell therapy for HIV infection in a Phase 1 trial. Frontiers in Medicine. 9. 1044713–1044713. 5 indexed citations
2.
Li, Haishan, Tyler Lahusen, Nidal Muvarak, et al.. (2020). Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, LentivirusModified CD4 T Cells for HIV Functional Cure. Molecular Therapy — Methods & Clinical Development. 17. 1048–1060. 8 indexed citations
3.
Muvarak, Nidal, Carine Robert, Limin Xia, et al.. (2017). Abstract IA13: Combination of DNA methyltransferase and PARP inhibitors as a novel therapy strategy for multiple cancers: Key data in AML and triple negative breast cancer. Cancer Research. 77(22_Supplement). IA13–IA13. 2 indexed citations
4.
Muvarak, Nidal, Limin Xia, Carine Robert, et al.. (2016). Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for Cancer. Cancer Cell. 30(4). 637–650. 144 indexed citations
5.
6.
Muvarak, Nidal, Carine Robert, Maria R. Baer, et al.. (2015). c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias. Molecular Cancer Research. 13(4). 699–712. 54 indexed citations
7.
Emadi, Ashkan, Mariola Sadowska, Brandon Carter‐Cooper, et al.. (2013). Dimeric Naphthoquinones: Novel Anti-Leukemic Agents Modulating Cellular Redox Status. Blood. 122(21). 1290–1290. 2 indexed citations
8.
Muvarak, Nidal, Pratik Nagaria, & Feyruz V. Rassool. (2012). Genomic Instability in Chronic Myeloid Leukemia: Targets for Therapy?. Current Hematologic Malignancy Reports. 7(2). 94–102. 19 indexed citations
9.
Stitelman, David H., Masayuki Endo, Nidal Muvarak, et al.. (2010). Robust In Vivo Transduction of Nervous System and Neural Stem Cells by Early Gestational Intra Amniotic Gene Transfer Using Lentiviral Vector. Molecular Therapy. 18(9). 1615–1623. 15 indexed citations
10.
Sadowska, Mariola, Nidal Muvarak, Rena G. Lapidus, et al.. (2010). Single Agent Activity of the Cyclin-Dependent Kinase (CDK) Inhibitor Dinaciclib (SCH 727965) In Acute Myeloid and Lymphoid Leukemia Cells. Blood. 116(21). 3981–3981. 2 indexed citations
11.
Kondaskar, Atul, Raj Kumar, James C. Fishbein, et al.. (2010). Novel, Broad Spectrum Anticancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring System. ACS Medicinal Chemistry Letters. 2(3). 252–256. 51 indexed citations
12.
Behrens, Edward M., et al.. (2008). Apoptotic Cell-Mediated Immunoregulation of Dendritic Cells Does Not Require iC3b Opsonization. The Journal of Immunology. 181(5). 3018–3026. 7 indexed citations
13.
Niiya, Masami, Masayuki Endo, Dezhi Shang, et al.. (2008). Correction of ADAMTS13 Deficiency by In Utero Gene Transfer of Lentiviral Vector encoding ADAMTS13 Genes. Molecular Therapy. 17(1). 34–41. 47 indexed citations
14.
Peranteau, William H., Ping Zhang, Nidal Muvarak, et al.. (2008). IL-10 Overexpression Decreases Inflammatory Mediators and Promotes Regenerative Healing in an Adult Model of Scar Formation. Journal of Investigative Dermatology. 128(7). 1852–1860. 233 indexed citations
15.
Endo, Masayuki, Philip W. Zoltick, Daniel C. Chung, et al.. (2007). Gene Transfer to Ocular Stem Cells by Early Gestational Intraamniotic Injection of Lentiviral Vector. Molecular Therapy. 15(3). 579–587. 41 indexed citations
16.
Endo, Masayuki, Philip W. Zoltick, William H. Peranteau, et al.. (2007). Efficient In Vivo Targeting of Epidermal Stem Cells by Early Gestational Intraamniotic Injection of Lentiviral Vector Driven by the Keratin 5 Promoter. Molecular Therapy. 16(1). 131–137. 42 indexed citations
17.
Muvarak, Nidal, et al.. (2004). Linked mechanical and biological aspects of remodeling in mouse pulmonary arteries with hypoxia-induced hypertension. American Journal of Physiology-Heart and Circulatory Physiology. 288(3). H1209–H1217. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angus M. Tester Breakdown of academic impact, for papers by Carola Leipner Breakdown of academic impact, for papers by Seong‐Jin Kim Breakdown of academic impact, for papers by Dean Kavanagh Breakdown of academic impact, for papers by Françoise Créchet Breakdown of academic impact, for papers by Sarah E. Dunsmore Breakdown of academic impact, for papers by Teresa I. Mitchell Breakdown of academic impact, for papers by Robert O. Mitchell Breakdown of academic impact, for papers by Aline B. Scandurro Breakdown of academic impact, for papers by Qinglang Li
Rankless by CCL
2026